Targeting Signal-Transducer-and-Activator-of-Transcription-3 for Prevention and Therapy of Cancer
Recent evidence indicates a convergence of molecular targets for both prevention and therapy of cancer. Signal-transducer-and-activator-of-transcription-3 (STAT3), a member of a family of six different transcription factors, is closely linked with tumorigenesis. Its role in cancer is indicated by numerous avenues of evidence, including the followin
cancer stat3 interleukin-6 chemoresistance